BioLayer Corporation Limited (ADO) - Financial and Strategic SWOT Analysis Review

BioLayer Corporation Limited (ADO) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

BioLayer Corporation Limited (BioLayer) formerly AnteoTech Ltd is a leading medical technology company that develops and commercializes healthcare products. The company along with its subsidiaries is a provider of Immunoassays, In-vitro Diagnostics, and Point of Care (PoC) tests to entities involved in the life sciences, bio-separation, and medical device markets. It offers major offerings include AnteoCoat, AnteoX, AnteoBind and AnteoRelease. The company uses its surface management technology for the development of its products. BioLayer is headquartered in Brisbane, Queensland, Australia.

BioLayer Corporation Limited Key Recent Developments

Apr 21,2022: AnteoTech : Appointment of Ewen Crouch AM as Non-Executive Chairman
Mar 22,2022: AnteoTech : CEO succession
Mar 14,2022: AnteoTech : Chair Succession Initiated/ Christopher Parker to resume as an Executive Director
Feb 09,2022: AnteoTech: TGA registration update (3)

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
BioLayer Corporation Limited - Key Facts
BioLayer Corporation Limited - Key Employees
BioLayer Corporation Limited - Key Employee Biographies
BioLayer Corporation Limited - Major Products and Services
BioLayer Corporation Limited - History
BioLayer Corporation Limited - Company Statement
BioLayer Corporation Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
BioLayer Corporation Limited - Business Description
Product Category: License fees and Royalties
Performance
Product Category: Product Sales
Performance
BioLayer Corporation Limited - Corporate Strategy
BioLayer Corporation Limited - SWOT Analysis
SWOT Analysis - Overview
BioLayer Corporation Limited - Strengths
BioLayer Corporation Limited - Weaknesses
BioLayer Corporation Limited - Opportunities
BioLayer Corporation Limited - Threats
BioLayer Corporation Limited - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
BioLayer Corporation Limited, Medical Equipment, Deals By Year, 2016 to YTD 2022
BioLayer Corporation Limited, Medical Equipment, Deals By Type, 2016 to YTD 2022
BioLayer Corporation Limited, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 21, 2022: AnteoTech : Appointment of Ewen Crouch AM as Non-Executive Chairman
Mar 22, 2022: AnteoTech : CEO succession
Mar 14, 2022: AnteoTech : Chair Succession Initiated/ Christopher Parker to resume as an Executive Director
Feb 09, 2022: AnteoTech: TGA registration update (3)
Dec 22, 2021: AnteoTech: $1.96 million R&D tax incentive refund received
Sep 01, 2021: AnteoTech positions Board for growth and establishes Advisory Boards
Aug 20, 2021: AnteoTech announce resignation of chief financial officer
Aug 02, 2021: AnteoTech renews and extends CEO contract
Apr 22, 2021: AnteoTech announces resignation of director
Mar 31, 2021: AnteoTech appoints Chief Financial Officer
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
BioLayer Corporation Limited, Key Facts
BioLayer Corporation Limited, Key Employees
BioLayer Corporation Limited, Key Employee Biographies
BioLayer Corporation Limited, Major Products and Services
BioLayer Corporation Limited, History
BioLayer Corporation Limited, Subsidiaries
BioLayer Corporation Limited, Key Competitors
BioLayer Corporation Limited, Annual Ratios
BioLayer Corporation Limited, Annual Ratios (Cont...1)
BioLayer Corporation Limited, Interim Ratios
BioLayer Corporation Limited, Medical Equipment, Deals By Year, 2016 to YTD 2022
BioLayer Corporation Limited, Medical Equipment, Deals By Type, 2016 to YTD 2022
BioLayer Corporation Limited, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
BioLayer Corporation Limited, Performance Chart (2018 - 2022)
BioLayer Corporation Limited, Ratio Charts
BioLayer Corporation Limited, Medical Equipment, Deals By Year, 2016 to YTD 2022
BioLayer Corporation Limited, Medical Equipme

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings